Skip to Content

APO 055 (Selegiline 5 mg)

Pill imprint APO 055 has been identified as Selegiline hydrochloride 5 mg.

Selegiline is used in the treatment of parkinson's disease; major depressive disorder; depression; adhd and belongs to the drug classes dopaminergic antiparkinsonism agents, monoamine oxidase inhibitors. Risk cannot be ruled out during pregnancy. Selegiline 5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Selegiline hydrochloride 5 mg APO 055
Selegiline hydrochloride 5 mg APO 055 Front
Selegiline hydrochloride 5 mg APO 055 Back
Selegiline hydrochloride 5 mg APO 055
Selegiline hydrochloride
Imprint:
APO 055
Strength:
5 mg
Color:
Blue & White
Size:
16.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Monoamine oxidase inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Apotex Corp.
National Drug Code (NDC):
60505-0055
Inactive Ingredients:
lactose anhydrous
citric acid anhydrous
microcrystalline cellulose
stearic acid
magnesium silicate
gelatin
FD&C Blue No. 1
titanium dioxide
ammonia
ferrosoferric oxide
alcohol
isopropyl alcohol
potassium hydroxide
propylene glycol
water
shellac
butyl alcohol

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide